The world's first human challenge trial for a vaccine against SARS-CoV-2 is set to begin in London in January. Human challenge trials for the SARS-CoV-2 virus have many challenges, including producing a strain that is less virulent, but Dr. Gagandeep Kang says such trials can provide information and help design better vaccines than we can do now with conventional trials.
Human challenge studies
WHO backs COVID-19 vaccine trials that deliberately infect participants
In new guidelines issued on May 6, WHO has backed human challenge studies for COVID-19 vaccines on the ground that it could both accelerate vaccine development and make the final vaccine far more effective. In new guidelines issued on May 6, the World Health Organization has said that well-designed human challenge studies could not only … Continue reading WHO backs COVID-19 vaccine trials that deliberately infect participants
Science Chronicle 